Skip to main content

Advertisement

Table 1 Growth inhibitory activities (GI50)(μg/ml) of various anti-cancer agents against 10 human lung cancer cell lines – Set 1

From: Anticancer drug clustering in lung cancer based on gene expression profiles and sensitivity database

Drug           
  PC7 PC9 PC14 A549 Lu65 LK-2 H69 N231 Lu135 SBC-3
CDDP 4.55 3.53 2.86 5.46 3.39 4.72 1.64 1.25 0.22 4.84
SN38 5.05 3.45 3.79 6.80 0.48 4.25 0.77 0.66 0.05 0.07
VIN 2.64 1.43 >10 >10 0.06 0.02 0.02 0.01 0.02 0.51
DOC 2.46 21.34 20.38 21.31 3.61 26.31 4.72 6.04 0.53 >50
GEM <0.05 14.28 >500 >500 79.53 54.61 3.73 3.88 <0.05 <0.05
5FU 2.76 5.84 >10 >10 8.76 >10 >10 >10 5.68 0.51
CBDCA 95 70 >100 46.3 71 0.225 7.54 45 61 3.5
PAC 6.7 39 34 51 34 20 <0.001 7 5.5 0.5